Detalles de la búsqueda
1.
The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden: Looking beyond health costs.
Diabetes Obes Metab
; 24(6): 1038-1046, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35137507
2.
The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data.
Diabetes Obes Metab
; 23(7): 1604-1613, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33729661
3.
Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden.
Diabetologia
; 63(12): 2582-2594, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32968866
4.
Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study.
Health Qual Life Outcomes
; 14: 13, 2016 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26801908
5.
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting.
Pharmacoecon Open
; 6(3): 343-354, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35064550
6.
Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden.
Scand J Public Health
; 39(1): 79-87, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20688795
7.
Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis.
Diabetes Ther
; 12(1): 373-388, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33306169
8.
Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective.
J Med Econ
; 23(11): 1311-1320, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32746676
9.
Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort.
Eur J Health Econ
; 10(2): 217-26, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18853206
10.
Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden.
J Med Econ
; 22(10): 997-1005, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31044636
11.
Evaluation of the Cost Per Patient Achieving Treatment Targets with Oral Semaglutide: A Short-Term Cost-Effectiveness Analysis in the United States.
Adv Ther
; 36(12): 3483-3493, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31650514
12.
Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes.
PLoS One
; 13(2): e0191953, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29408938
13.
Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden.
Diabetes Ther
; 9(1): 87-99, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29204855
14.
Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden.
Appl Health Econ Health Policy
; 15(2): 237-248, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28063135
15.
Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data.
Curr Med Res Opin
; 33(4): 647-655, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28035840
16.
Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone.
Pharmacoeconomics
; 23(4): 365-75, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15853436
17.
Costs of COPD in Sweden according to disease severity.
Chest
; 122(6): 1994-2002, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12475838
18.
Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
Maturitas
; 74(3): 259-63, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23312488
19.
Effects of the g factor in semiclassical kinetic plasma theory.
Phys Rev Lett
; 101(24): 245002, 2008 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-19113628
20.
Cost differences for COPD with and without physician-diagnosis.
COPD
; 2(4): 427-34, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17147008